Anesthesia
- Statement on Practice Recommendations for Pediatric Anesthesia
- Sugammadex and recurarization in an infant
- Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study
- Sugammadex: Applications in Pediatric Critical Care
- Smart Tots
Gastroenterology
- Cryptosporidiosis
- Giardiasis
- For Parents: Treating Pediatric Dehydration
- Swimming Pool Hygiene
- Children’s Health
- GI Kids
Psychiatry
Respiratory Syncytial Virus (RSV)
- CDC: FAQs About RSV Immunization with mAb for Children ≤ 19 Months
- JAMA: Trends in Age and Disease Severity in Children Hospitalized With RSV Infection Before and During the COVID-19 Pandemic
- AAP Nirsevimab Administration Visual Guide
- Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
- ACOG RSV Prevention Practice Advisory
- For Healthcare Providers: RSV Prevention Information
- MMWR: ACIP Recommendations for Nirsevimab
- MMWR: ACIP Recommendations for Maternal RSV Vaccine
- Nirsevimab Prescribing Information
- Maternal RSV Vaccine Prescribing Information
- Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE)
- Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak
- CDC Recommendations for RSV Prevention
- Phase 3 MELODY: Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants
- 2024 Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger
- Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
- CDC: RSV Vaccination for Pregnant People
- Patient Brochure: RSV in Infants and Young Children
Vaccine-preventable Diseases: General
Vaccine-preventable Diseases: Influenza
- Flu: A Guide for Parents
- Frequently Asked Influenza (Flu) Questions: 2024-2025 Season
- No More Excuses: You Need a Flu Vaccine
- Make a Strong Influenza Vaccine Recommendation
- Influenza Activity in the United States during the 2023–2024 Season and Composition of the 2024–2025 Influenza Vaccine
- Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing
- Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018–19 Influenza Season in the United States
- A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017–18 influenza season – ScienceDirect
- Recommendations for Prevention and Control of Influenza in Children, 2022-2023
- Recommendations for Prevention and Control of Influenza in Children, 2022–2023
Vaccine-preventable Diseases: Human Papillomavirus (HPV)
- HPV vaccine promotion: Snapshot of two health departments during the COVID-19 pandemic
- Understanding primary care physician perspectives on recommending HPV vaccination and addressing vaccine hesitancy
- Top 10 Tips for HPV Vaccination Success
- CDC: ACIP’s HPV Vaccination Recommendations
- CDC: Talking to Parents about HPV Vaccine
- Pediatric Vaccination – Information for Parents
- CDC Resources, Education & References for HPV Vaccination
- Human Papillomavirus Vaccination: ACOG Committee Opinion Vaccination
- HPV Vaccination: What Everyone Should Know
- CDC HPV Vaccine Recommendations
- Standing Order for HPV Vaccine
- Centers for Disease Control and Prevention HPV Vaccine Recommendations
- Recommended Immunization Schedule for Persons Aged 0 Through 18 Years (United States, 2024) – Educational Tool for Clinicians and Nurses
- Why Are Childhood Vaccines So Important? – Educational Tool for Parents
